Access cutting-edge lupus nephritis treatment through this clinical trial at a research site in Philadelphia. Study-provided care at no cost to qualified participants.
Access lupus nephritis specialists in Philadelphia at no cost
This study follows strict safety protocols and ethical guidelines
All study-related lupus nephritis treatment provided free
A Study of Anti-CD19 Chimeric Antigen Receptor T Cell Therapy for Subjects With Refractory Lupus Nephritis
Sponsor: Kyverna Therapeutics
Check if you qualify for this lupus nephritis clinical trial in Philadelphia, PA
If you're searching for lupus nephritis treatment options in Philadelphia, PA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Philadelphia research site is actively enrolling participants for this clinical trial. You'll receive care from experienced lupus nephritis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.